The Economic and Clinical Efficiency of Point-of-Care Testing for Critically Ill Patients: A Decision-Analysis Model

American Journal of Medical Quality

Volumn 13, Issue 1, 1998, Pages 3-12

  Halpern, Michael T ^a   Palmer, Cynthia S ^a   Simpson, Kit N ^b   Chesley, Francis D ^c   Luce, Bryan R ^a   Suyderhoud, Johan P ^d   Neibauer, Bonnie V ^e   Estafanous, Fawzy G ^f  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b IL   (United States)

^c AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WASHINGTON ADVENTIST HOSPITAL   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GAS ANALYSIS; CORONARY ARTERY BYPASS GRAFT; DECISION SUPPORT SYSTEM; ECONOMICS; HOSPITAL COST; HOSPITAL INFORMATION SYSTEM; HOSPITAL LABORATORY; HUMAN; INSTRUMENTATION; INTENSIVE CARE; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; REVIEW; TASK PERFORMANCE; UNITED STATES;

BLOOD GAS ANALYSIS; CORONARY ARTERY BYPASS; CRITICAL CARE; DECISION SUPPORT SYSTEMS, CLINICAL; HOSPITAL COSTS; HUMANS; LABORATORIES, HOSPITAL; OUTCOME ASSESSMENT (HEALTH CARE); POINT-OF-CARE SYSTEMS; POSTOPERATIVE PERIOD; TIME AND MOTION STUDIES; UNITED STATES;

EID: 0032013022     PISSN: 10628606     EISSN: None     Source Type: Journal    
DOI: 10.1177/106286069801300102     Document Type: Article

References (26)

1. Meyerhoff ME. New in vitro analytical approaches for clinical chemistry measurements in critical care. Clin Chem 1990;36:1567-1572.
2. Zaloga GP, Dudas L, Roberts P, et al. Near-patient blood gas and electrolyte analyses are accurate when performed by non-laboratory-trained individuals. J Clin Monit 1993;9:341-346.
3. Chernow B. Blood conservation in critical care - The evidence accumulates. Crit Care Med 1993;21:481-482.
4. McQueen MJ. The ethics and economics of out-of-laboratory testing. Can Med Assoc J 1993;149:1653-1656.
5. Simpson K, LaVallee R, Halpern M. Modeling the cost-effectiveness of bedside testing: Coronary artery bypass patients in intensive care units. MLO 1996;28:58-62.
6. Gravenstein JS. Modern trends in monitoring in anaesthesia: Its benefits and costs. Eur Heart J 1989;10(Supp H):28-32.
7. Jones BA. Testing at the patient's bedside. Clin Lab Med 1994;14:473-491.
8. Roizen MF, Schreider B, Austin W, et at. Pulse oximetry, capnography, and blood gas measurement: Reducing cost and improving the quality of care with technology. J Clin Monit 1993;9:237-240.
9. Kellerman AL, Cofer CA, Joseph S, et al. Impact of portable pulse oximetry on arterial blood gas test ordering in an urban emergency department. Ann Emerg Med 1991;20:130-134.
10. Zaloga GP, Hill TR, Strickland RA, et al. Bedside blood gas and electrolyte monitoring in critically ill patients. Crit Care Med 1989;17:920-925.
11. Strickland RA, Hill TR, Zaloga GP. Bedside analysis of arterial blood gases and electrolytes during and after cardiac surgery. J Clin Anesth 1989;1:248-252.
12. Nosanchuk JS, Keefner R. Cost analysis of point-of-care laboratory testing in a community hospital. Am J Clin Pathol 1995;103:240-243.
13. Jatlow P. Point of care testing in the emergency department. Am J Clin Pathol 1993;100-591.
14. Buckingham K, Russell I, Ross I, et al. The effect of allowing clinical discretion in ordering biochemical tests. Int J Technol Assess Health Care 1994;10:695-709.
15. Benge H, Csako G, Parl FFA 10-year analysis of "revenues," costs, staffing, and workload in an academic medical center clinical chemistry laboratory. Clin Chem 1993;39:1780-1787.
16. Hardwick DF, Husted A, Dimmick JE. Economic analysis of the clinical laboratory: labor implications. Mod Pathol 1993;6:220-224.
17. Taylor GJ, Mikell FL, Moses HW, et al. Determinants of hospital charges for coronary artery bypass surgery: The economic consequences of postoperative complications. Am J Cardiol 1990;65:309-313.
18. Munoz E, Thies H, Maesaka JK, et al. Diagnosis related groups, resource utilization, age, and outcome for hospitalized nephrology patients. Am J Kidney Dis 1988;11:481-488.
19. Bennet BR, Jacobs LM, Schwartz RJ. Incidence, costs, and DRG-based reimbursement for traumatic brain injured patients: A 3-year experience. J Trauma 1989;29:556-565.
20. McMordie WR, Barker SL. The financial trauma of head injury. Brain Inj 1988;2:357-364.
21. Forbes JM, Anderson MD, Anderson GF, et al. Blood transfusion costs: A multicenter study. Transfusion 1991;31:318-323.
22. Hellinger FJ. The lifetime cost of treating a person with HTV. JAMA 1993;270:474-478.
23. Oddone EZ, Cowper PA, Hamilton JD, et al. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients. Health Serv Res 1993;28:97-121.
24. Silverstein MD, Mulley AG, Dienstag JL. Should donor blood be screened for elevated alanine aminotransferase levels? A cost-effectiveness analysis. JAMA 1984;252:2839-2845.
25. Kay HR, Armenti FR, Parr GVS. Results to expect in today's older and sicker cardiac patients. Geriatrics 1989;44:67-70.
26. National Center for Health Statistics. Vital Statistics of the United States, Life Tables, 1989; Vol. 11, Sect. 6. Washington: Public Health Service, 1992.